3738521

Degradable PEG-lipids for lipid nanoparticle mRNA formulation

Date
August 23, 2022

Lipid nanoparticles (LNPs) are non-viral carriers which are widely used for the delivery of nucleic acid based drugs, including mRNA, which are prone to degradation, sub-optimal pharmacokinetics and poor intracellular delivery in unformulated from. [1] Such LNPs are generally composed of an ionizable cationic lipid, cholesterol, a phospholipid, and a PEGylated lipid (PEG: poly(ethylene glycol)). The latter is crucial for limiting LNP size, colloidal stability and influencing biodistribution in vivo. PEG is a non-degradable polymer and has limited options to introduce functionality along its backbone. [2] Here we demonstrate a straightforward route which concomitantly introduces degradability and functionality onto existing PEG and PEG-lipids and demonstrate its usefulness for mRNA LNP formulation. The commercially available PEG lipid DMG-PEG (1,2-Dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000) was modified in a single step with either a carboxylic acid-functionalized TAD (acidTAD) or a butyl-functionalized TAD (buTAD) compound. Under irradiation of 520 nm light, a hemi-aminal bond is formed between the TAD and the ether repeating unit in PEG [3]. Degradation of the hemi-aminal in aqueous medium leads to low molecular weight PEG oligomers with reaction kinetics depending on pH and temperature, showing accelerated kinetics at 40 °C at both neutral and acidic pH, whereas slower kinetics were observed at room temperature and basic pH. The obtained DMG-PEG-acidTAD and DMG-PEG-buTAD could successfully be used for mRNA LNP formulation, showing similar size and encapsulation efficiency compared to native DMG-PEG, albeit with a negative zeta-potential due to the chemical nature of the TAD-conjugate. In vitro evaluation on 2D cell cultures showed lack of toxicity of the TAD-modification and increased mRNA transfection efficiency of the LNP without increasing LNP uptake. Studies to elucidate the underlying reason for the improved transfection efficiency and the influence of TAD-modification on in vivo biodistribution and mRNA transfection are currently ongoing.

Related Products

Thumbnail for Activating innate anti-tumor immune killing by antibody-recruiting hapten-lipid dendrimers
Activating innate anti-tumor immune killing by antibody-recruiting hapten-lipid dendrimers
Exploiting innate immune effector mechanisms against the Fc domain of monoclonal antibodies (mAbs) is gaining immense popularity in anti-cancer therapy…
Thumbnail for A novel library of degradable ionizable lipids for mRNA immunotherapy
A novel library of degradable ionizable lipids for mRNA immunotherapy
Intracellular delivery of mRNA represents one of the greatest challenges due to the fragility of mRNA and the difficulty to destabilize the endosomal membrane. One of the most advanced non-viral delivery systems for mRNA are lipid nanoparticles (LNPs)…
Thumbnail for Light-Stabilised Dynamic Materials at the Macro-, Micro- and Nanoscale: Breaking covalent bonds with the mildest trigger of all?
Light-Stabilised Dynamic Materials at the Macro-, Micro- and Nanoscale: Breaking covalent bonds with the mildest trigger of all?
The ability of photoswitches to reversibly undergo a photochemical response continues to highly impact the field of materials science, most notably in the design of molecular machines that can undergo translational or rotary motion that is fuelled by light…
Thumbnail for Lipid-PEG-fentanyl bio-conjugates as a hapten design for lipid nanoparticle templated anti-fentanyl vaccines
Lipid-PEG-fentanyl bio-conjugates as a hapten design for lipid nanoparticle templated anti-fentanyl vaccines
The opioid use disorder epidemic is ravaging the western society, with high rates of relapse and overdose deaths. Anti-opioid vaccines could reduce long-term opioid (ab)use and the risk of accidental overdose…